Breaking β Cell Tolerance After 100 Years of Life: Intratumoral Immunotherapy–Induced Diabetes Mellitus

Cancer immunotherapies are changing the landscape of cancer care. Intratumoral talimogene iaherparepvec (T-VEC), an oncolytic viral vaccine, has been approved for treatment of unresectable melanoma with minimal toxicity. We describe the first case of a centenarian who developed autoimmune diabetes w...

Descripción completa

Detalles Bibliográficos
Autores principales: Quandt, Zoe, Coupe, Catherine, Anderson, Mark, Uihlein, Alexander, Young, Arabella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491923/
https://www.ncbi.nlm.nih.gov/pubmed/32964173
http://dx.doi.org/10.1210/jendso/bvaa114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491923/
https://www.ncbi.nlm.nih.gov/pubmed/32964173
http://dx.doi.org/10.1210/jendso/bvaa114

Ejemplares similares